[Form 4] Ulta Beauty, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ulta Beauty director Martin Brok received a grant of 277 restricted stock units (RSUs) on 09/01/2025, recorded as a non‑derivative acquisition at a grant price of $0. After the grant, the reporting person beneficially owned 1,277 shares of Ulta Beauty common stock in a direct form. The RSUs vest 100% on 09/01/2026, per the form's explanation. The Form 4 was filed by a single reporting person and signed by an attorney‑in‑fact on 09/03/2025. This disclosure documents a routine equity compensation award to a director and the resulting change in direct beneficial ownership.

Insights

Financial Analyst

TL;DR: Small, routine director equity grant — immaterial to financials but aligns interests with shareholders.

The Form 4 reports a grant of 277 RSUs to Director Martin Brok on 09/01/2025, vesting fully on 09/01/2026 and recorded at $0 paid. The post‑transaction direct beneficial ownership is 1,277 shares. From a financial perspective, this transaction reflects standard equity compensation and is unlikely to affect Ulta Beauty's reported results or outstanding share count until vesting and delivery occur. It signals continued use of equity incentives for non‑employee directors rather than cash, which modestly aligns director incentives with shareholder outcomes.

Corporate Governance Expert

TL;DR: Routine governance disclosure showing director compensation via RSUs with a one‑year vesting schedule.

The filing documents compliance with Section 16 reporting requirements for a director award: 277 restricted stock units granted 09/01/2025, vesting 09/01/2026. The Form 4 was filed by one reporting person and signed by an attorney‑in‑fact on 09/03/2025. This is a standard disclosure showing transparency of insider holdings and timing of equity award vesting; there is no indication of accelerated vesting, transfers, or derivative transactions in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Brok Martin

(Last) (First) (Middle)

1000 REMINGTON BLVD

(Street)

BOLINGBROOK IL 60440

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2025		A		277(1)	A	$0	1,277	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of 277 restricted stock units, vesting 100% on 9/1/2026.

	Rene G. Casares, as attorney-in-fact for Martn Brok	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ulta Beauty director Martin Brok receive on 09/01/2025 (ULTA)?

He received a grant of 277 restricted stock units (RSUs) on 09/01/2025, vesting 100% on 09/01/2026.

How many Ulta Beauty shares does the reporting person beneficially own after the transaction?

The reporting person beneficially owned 1,277 shares of Ulta Beauty common stock following the reported transaction.

Was any cash paid for the RSU grant reported on the Form 4?

No cash was reported; the transaction lists a price of $0, indicating an equity grant rather than a purchase.

Who filed and signed the Form 4 for Martin Brok?

The Form 4 indicates it was filed by one reporting person and was signed by Rene G. Casares as attorney‑in‑fact on 09/03/2025.

When do the RSUs granted to Martin Brok vest?

The RSUs vest 100% on 09/01/2026 according to the form's explanation of responses.